Increasing recognition of the need to include patient preference measures into research on cancer treatment and outcomes.1-4 Limited past research on patient preferences in cancer patients, particularly in quantitative studies. The CanCORS study includes several patient preference measures. 3 Background A better understanding of the link between preferences and demographic / socio-economic variables is necessary before including them as predictors of treatment choice and outcomes. { How much variation in preferences is already explained by demographic and socio-economic variables? Past research provides some evidence of a link between demographic/socio-economic factors and preferences. { Older patients favor quality of life over quantit...
Juan Marcos González,1 Sarika Ogale,2 Robert Morlock,2 Joshua Posner,1 Brett Hauber,1 Nicolas...
PURPOSE: Clinicians often make decisions for their patients, despite evidence that suggests that cor...
INTRODUCTION: Primary endocrine therapy (PET) is used variably in the UK as an alternative to surger...
Introduction: Lung cancer is the deadliest and most prevalent cancer worldwide. Lung cancer treatmen...
In oncology, treatment outcomes can be competing, which means that one treatment could benefit one o...
Summary: A systematic review of the literature about patients’ preferences for involvement in canc...
Our objective was to determine how patient preferences guide the course of palliative chemotherapy f...
Objectives: There is increasing interest in studies that examine patient preferences to measure heal...
Background: Advanced treatment options for non-small cell lung cancer (NSCLC) consist of immunothera...
Our study objective was to determine lung cancer chemotherapy attributes that are important to patie...
This exploratory, descriptive study was designed to describe health care preferences among cancer pa...
Objective Lung cancer is a major cause of cancer-related deaths and thus represents a global health ...
Successful implementation of treatment in cancer care partially depends on how patients’ perspective...
Background: Advanced treatment options for non-small cell lung cancer (NSCLC) consist of immunothera...
Aim The global burden of colorectal cancer (CRC) is set to increase by 60% by 2030. An aging popula...
Juan Marcos González,1 Sarika Ogale,2 Robert Morlock,2 Joshua Posner,1 Brett Hauber,1 Nicolas...
PURPOSE: Clinicians often make decisions for their patients, despite evidence that suggests that cor...
INTRODUCTION: Primary endocrine therapy (PET) is used variably in the UK as an alternative to surger...
Introduction: Lung cancer is the deadliest and most prevalent cancer worldwide. Lung cancer treatmen...
In oncology, treatment outcomes can be competing, which means that one treatment could benefit one o...
Summary: A systematic review of the literature about patients’ preferences for involvement in canc...
Our objective was to determine how patient preferences guide the course of palliative chemotherapy f...
Objectives: There is increasing interest in studies that examine patient preferences to measure heal...
Background: Advanced treatment options for non-small cell lung cancer (NSCLC) consist of immunothera...
Our study objective was to determine lung cancer chemotherapy attributes that are important to patie...
This exploratory, descriptive study was designed to describe health care preferences among cancer pa...
Objective Lung cancer is a major cause of cancer-related deaths and thus represents a global health ...
Successful implementation of treatment in cancer care partially depends on how patients’ perspective...
Background: Advanced treatment options for non-small cell lung cancer (NSCLC) consist of immunothera...
Aim The global burden of colorectal cancer (CRC) is set to increase by 60% by 2030. An aging popula...
Juan Marcos González,1 Sarika Ogale,2 Robert Morlock,2 Joshua Posner,1 Brett Hauber,1 Nicolas...
PURPOSE: Clinicians often make decisions for their patients, despite evidence that suggests that cor...
INTRODUCTION: Primary endocrine therapy (PET) is used variably in the UK as an alternative to surger...